|
Orthologous residues
|
|
POLR2A (human): S1619‑p, POLR2A var1 (human): S1619‑p, POLR2A (mouse): S1619‑p, POLR2A (rat): S1619‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Relevant cell lines - cell types - tissues:
ES (stem)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
flavopiridol
|
|
|
|
no change compared to control
|
|
|
tamoxifen
|
|
|
|
decrease
|
48h treatment S5 POLR2A at promoter and coding region of bivalent genes
|
|
|
|
|
|
increase
|
bivalent chromatin domains
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
transcription, altered
|
|
Comments:
low level transcription of bivalent genes
|